Patent and Trademark
More on Patent and Trademark
"Mr. Chairman, the United States Patent and Trademark Office plays a vital role in fostering innovation in this country. The thousands of employees who examine patent and trademark applications are truly at the forefront of helping to bring new technologies and new companies into existence, each with the potential of being the next game-changer or Fortune 500 company.
Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a hearing on "Oversight of the U.S. Copyright Office:"
Washington, D.C. - Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a Subcommittee on Antitrust, Commercial, and Administrative Law hearing on "Treating the Problem: Addressing Anticompetitive Conduct and Consolidation in Health Care Markets:"
"The Judiciary Committee has a strong, bipartisan tradition of promoting competition in health care markets. We have done this vital work to make health care services-particularly prescription drugs-more affordable for patients.
|
Washington, D.C. – Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks, as prepared, during the markup of H.R. 6196, the Trademark Modernization Act of 2020: |
Washington, D.C. – Yesterday, House Judiciary Committee Chairman Jerrold Nadler (D-NY-10) joined Representative Lucy McBath (D-GA-06) in applauding the House passage of H.R. 7259, the Patents for Humanity Program Improvement Act. The legislation, introduced by Rep. McBath earlier this month,strengthens incentives for innovators to use their talents to solve global humanitarian challenges, and is co-sponsored by Rep. Ben Cline (R-VA-06), Rep. |
|
Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 5133, the Affordable Prescriptions for Patients Through Promoting Competition Act of 2019: |
|
Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during the markup of H.R. 3991, the Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act of 2019: |
|
Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement for the Subcommittee on Courts, Intellectual Property, and the Internet hearing on "The Patent Trial and Appeal Board and the Appointments Clause: Implications of Recent Court Decisions": |